Yosef Manla, MD, FESC
@ManlaYosef
Followers
250
Following
2K
Statuses
164
Postdoc-Scientist @SmidtHeart-@CedarsSinai | Former Research Scholar @ Cleveland Clinic @CCAD| FESC @escardio | #HeartFailure enthusiast
Los Angeles, CA
Joined May 2021
Thrilled to join the @SmidtHeart @CedarsSinai as a Research Fellow to be working under the mentorship of Dr. Jon Kobashigawa. Extremely excited and grateful for this opportunity to contribute to innovative research in the field of heart transplantation!
3
0
30
RT @XMichaelJonesMD: New online! šļøPleased to share that our State-of-the-Art Review on SSc associated cardiovascular disease is now publisā¦
0
5
0
RT @XMichaelJonesMD: Excited to share that our paper āMacrophages Contribute to Cardiac Fibrosis and Diastolic Dysfunction in Systemic Scleā¦
0
18
0
@XMichaelJonesMD @JACCJournals @MarbanLab @SmidtHeart @YaleIMed @TheIbrahimLab @soussi_salwa @ThassioMesquita @AleCiulloPhD @rrogerslab Congratulations! Great work!
1
0
2
I am excited to share our recent publication @TheJHLT, demonstrating how therapeutic plasma exchange improves survival in patients experiencing severe primary graft dysfunction after heart transplantation. Link: Beyond grateful to my mentor, Dr.Kobashigawa, and the team @SmidtHeart for the support and guidance
1
7
29
RT @datsunian: One of my unintended passions is now exploring: How do we make #cardioonc succeed, 1 program at a time? @yosefmanla @DSadleā¦
0
1
0
So happy to reconnect with You, Obada! Keep up the great work!
Another highlight from the conference was reuniting with a great friend and my research mentor @ManlaYosef, whose contributions to the research surrounding Heart Failure continue to be profoundly impactful.
0
0
1
Presenting our findings on predictors of Ischemia reperfusion injury post heart transplant #AHA24 @SmidtHeart @CedarsSinaiMed We found that: Optimal prioritization of HTx candidates on the waitlist and use of ATG induction therapy seem to protect against immediate ischemia reperfusion injury post-HTx
3
1
15
RT @JanetWeiMD: Great #AHA2024 presentation from @CedarsCards Dr. Rashmi Jain: Highly sensitized patients treated with desensitization priā¦
0
3
0
Conclusion: Our study hints at better 5-year survival in HKTx recipients receiving pre-transplant D-MCS, which could be attributed to the findings of lower rates of AMR in this population
0
0
1
I am excited to present this weekend at the American Heart Association Scientific Sessions 2024 #AHA24! in Chicago! Celebrating 100 years of Cardiology science and hope! @AHAMeetings @AHAScience @SmidtHeart
Excited to share that our work @SmidtHeart on ischemia-reperfusion injury post-heart transplant, as well as our study on heart-kidney transplant patients bridged with D-MCS, has been selected for 3 moderated presentations at the American Heart Association Scientific Sessions 2024 #AHA2024 Grateful to Dr.Kobashigawa and the team for the mentorship and guidance.
2
1
12
RT @IHME_UW: GBD data highlights Pulmonary Arterial Hypertension (PAH)'s substantial burden worldwide, affecting women at a higher rate thaā¦
0
4
0
RT @robmentz: Hard to believe itās already the last day of July! Tune in for my summary of the July issue of JCF Impactful papers that infā¦
0
16
0
RT @SmidtHeart: .@USNews hospital ratings for 2024-25 rank @SmidtHeart #1 in California in the Cardiology, Cardiac & Vascular Surgery categā¦
0
8
0
Sharing alongside Dr.Bader @CleClinicHVTI @CCAD our recent Letter @JACCJournals on Heart failure Burden in Asia: In 2019, China, Jordan, and Kuwait had the highest Age-Standardized Prevalence of HF. Between 1990-2019, Oman, Saudi Arabia, and Syria had the highest increase in HF prevalence. š Linke to Our letter: The article we commented on: Author Response: #JACCASIA #Cardiology #HeartFailure
0
1
14
RT @EmadHakemiMD: 70 yo morbidly obese Hx of CVA/A.Fib > NYHA III LVEF 15-20% LBBB with Severe Aortic Regurgitation > R+L Bicuspid with Minā¦
0
5
0